Advertisement

Topics

MatBA - Mature B-cell neoplasm array - Biotech, Pharma and Life Science Channel

16:57 EDT 23rd October 2017 | BioPortfolio

Mature B-cell neoplasms arise in B-cells that have entered germinal centers within lymph nodes as part of the immune response. They display great heterogeneity at the clinical, pathologic, and genetic levels and represent 6-7% and 5-6% of all new estimated cancer cases and deaths respectively in the US in 2009. They are the fifth most common neoplasm in both males and females, and of the 103,960 estimated new cases in 2009, 20,860 comprise diffuse large B-cell lymphoma (DLBCL), 20,580 multiple myeloma (MM), 15,490 chronic lymphocytic leukemia /small lymphocytic lymphoma (CLL/SLL), 14,900 follicular lymphoma (FL), 8,510 Hodgkin’s lymphoma (HL), 6,000 marginal zone lymphomas (MZL) (including the three subtypes: extranodal marginal zone of mucosa-associated lymphoid tissue [MALT], nodal marginal zone, and splenic marginal zone), and 3,730 mantle cell lymphomas (MCL), as the major subtypes. With the exclusion of HL, 32,520 deaths are expected in 2009 in the US as a result of these neoplasms.

Diagnosis of these neoplasms relies mostly on the pathologic examination of biopsy material, be it either of an incisional or excisional biopsy of a suspect lymph node, a fine needle aspirate of a suspect lymph node (as yet to be considered adequate for initial diagnosis, unless it is the only safe option), or a bone marrow aspirate. Unlike other cancers, rarely are other biopsy/surgical procedures performed prior to the initiation of treatment, thus limiting the amount of tissue available for diagnostic and prognostic purposes. CGI has optimized the utility of array CGH so that it can be routinely applied to the study of a range of specimen types including formalin-fixed paraffin-embedded (FFPE) specimens, often the only specimen available for analysis.

Source: http://cancergenetics.com/cgi-research/cgh-microarray/ UMatBA is a Registered Trademark of CGI

PubMed Articles [17809 Associated PubMed Articles listed on BioPortfolio]

Redefining the effect of salt on thermophilic starter cell viability, culturability and metabolic activity in cheese.

This study investigated the differential effect of salt concentration in the outside and inside layers of brine salted cheeses on viability, culturability and enzyme activity of starter bacteria. The ...

Unravelling the contribution of the Penicillium expansum PeSte12 transcription factor to virulence during apple fruit infection.

Blue mould disease caused by Penicillium expansum infection is one of the most important diseases of pome fruit accounting for important economic losses. In the present study, the PeSte12 transcriptio...

Entry Studies of New World Arenaviruses.

Identification of cell moieties involved in viral binding and internalization is essential since their expression would render a cell susceptible. Further steps that allow the uncoating of the viral p...

A Cell-Cell Fusion Assay to Assess Arenavirus Envelope Glycoprotein Membrane-Fusion Activity.

For many viruses that enter their target cells through pH-dependent fusion of the viral and endosomal membranes, cell-cell fusion assays can provide an experimental platform for investigating the stru...

Studies of Lassa Virus Cell Entry.

Host cell entry is the first and most fundamental step of every virus infection and represents a major barrier for zoonotic transmission and viral emergence. Targeting viral entry appears further as a...

Expression and X-Ray Structural Determination of the Nucleoprotein of Lassa Fever Virus.

We describe methods to express the nucleoprotein (NP) of Lassa fever virus (LASV) in E. coli, to purify and crystallize it using the sitting-drop vapor diffusion method. The crystals were screened usi...

A Primary Human Liver Cell Culture Model for Hemorrhagic Fever Viruses.

Viral hemorrhagic fevers affect liver functions such as important metabolic processes and the replacement of new blood cells, coagulation factors, and growth factors. Typically, multi-organ diseases s...

Identifying Restriction Factors for Hemorrhagic Fever Viruses: Dengue and Junín.

Host restriction factors are cellular components that interfere with viral multiplication. They are up-regulated and expressed upon viral infection and in consequence their activity is specific. So fa...

Introduction to Cancer Stem Cells: Past, Present, and Future.

The Cancer Stem Cell (CSC) hypothesis postulates the existence of a small population of cancer cells with intrinsic properties allowing for resistance to conventional radiochemotherapy regiments and i...

The Role of CD44 and Cancer Stem Cells.

Solid tumors are composed of mutually interacting cancer cells and tumor microenvironment. Many environmental components, such as extracellular matrix (ECM), mesenchymal stem cells, endothelial and im...

News Articles [5316 Associated News Articles listed on BioPortfolio]

Stryker’s Spine Division to Launch Tritanium® C Anterior Cervical Cage at NASS 2017

Latest Addition to Tritanium Product Line Brings Benefits of 3D-Printed Implants that Mimic Porosity of Bone to Cervical Fusion Procedures Stryker’s Spine divi...

Number of mutations needed to cause cancer calculated

Between one and 10 mutations are required for a healthy cell to turn cancerous...

Metabolism Stress Test Kits

Product AnnouncementAMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluati...

NIH BRAIN Initiative launches cell census

$250 million effort will catalog “parts list” of our most complex organ.

Blocking cancer and cell cycle promoting proteins with a new miRNA family

Fox Chase Cancer Center researchers have discovered a new family of micro-RNAs that disrupt production of proteins essential to the growth and development of colorectal and other types of cancer cells...

Possible new anti-TB treatment path

As part of the long effort to improve treatment of tuberculosis (TB), microbiologists report that they have for the first time characterized a protein involved in making a glycolipid compound found in...

Building Blocks of Life May Have Formed in Water Droplets

Reactions that generate fundamental components of the cell run smoothly in microdroplets, study shows.

Study links mutations in notch gene to role in B cell cancers

In B cell tumors, mutated overactive versions of the Notch protein directly drive the expression of the Myc gene and many other genes that participate in B cell signaling pathways, researchers have fo...

NIH unveils brain cell census network

Dr. Roy Geronemus, M.D. at Laser & Skin Surgery Center of New York Received the NYSCF Leadership Award

CEO and Co-Founder of NYSCF, Susan L. Solomon, presents the 2017 NYSCF Leadership Award to Roy G. Geronemus, M.D.. NEW YORK (PRWEB) October 23, 2017 Roy Geronemus, M.D. was presented with the New Yor...

Events [0 Results]

None

Companies [497 Associated Companies listed on BioPortfolio]

Asklepios BioPharmaceutical, Inc.

AskBio is a private clinical-stage biotechnology company engaged in the development of novel, gene-transfer mediated therapies using a proprietary AAV-based vector technology plat...

Mission Bio, Inc.

Mission Bio, Inc. is innovating technologies to analyze single cells within complex biological systems, revealing critical information not observable from bulk sample analysis. Wi...

Engility Holdings, Inc.

Engility (NYSE: EGL) is engineered to make a difference. Built on six decades of heritage, Engility is a leading provider of integrated solutions and services, supporting U.S. gov...

WindMIL Therapeutics

When it comes to cell therapy – cell source matters. At WindMIL, we are harnessing the power of bone marrow derived lymphocytes (MILs™) to develop ground-breaking immuno...

Promethera Biosciences SA

Promethera Biosciences is a global innovator in liver cell-based medicines whose mission is to help patients overcome acute and chronic liver diseases. Our lead clinical program, ...

Selexis SA and Pelican Therapeutics

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

Be The Match BioTherapies

Be The Match BioTherapies partners with organizations pursuing life-saving cellular therapies in every stage of development—from discovery through commercialization. Built...

PPA Research Group

PPA Research Group is a biotechnology company dedicated to providing global life sciences with the highest quality hematologic tissues and cells that enable drug discovery, stem c...

Ology Bioservices, Inc.

Ology Bioservices, Inc. (formerly Nanotherapeutics, Inc.) is a biologics-focused contract development and manufacturing organization (CDMO) serving both government and commercial ...

Rubius Therapeutics

Red-Cell Therapeutics™ are genetically engineered, enucleated red cells that provide allogeneic, off-the-shelf therapies to patients across multiple therapeutic areas. RCT ad...

Clinical Trials [6065 Associated Clinical Trials listed on BioPortfolio]

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

This randomized phase II trial studies how well stem cell transplant with or without tbo-filgrastim works in treating patients with multiple myeloma or non-Hodgkin lymphoma. Eliminating th...

REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors

Each subject will participate in the trial until death, drop out, or loss-to follow-up from the time the subject signs the Informed Consent Form (ICF) through the final contact. After a sc...

Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance

Patients suffering from diffuse large B-cell lymphoma (DLBCL) who relapse within 12 months of chemotherapy usually undergo salvage therapies followed by autologous transplant but have low ...

Personal FET in RIF Patients According to Histological Dating of Endometrial of Natural/ Hormone Replacement Cycle

At present, the evaluation criterion of endometrial receptivity is controversial. The development of a molecular diagnostic tool, the endometrial receptivity array (ERA) for diagnosis of e...

Clinical Outcomes of Robotic Versus Laparoscopic Assisted Distal Gastrectomy for Gastric Cancer

The purpose of this study is to explore the clinical outcomes of the robotic assisted distal gastrectomy for patients with gastric adenocarcinoma(cT1-4a, N-/+, M0).

Priming Immunotherapy in Advanced Disease With Radiation

This study proposes to treat metastatic non-small cell lung cancer (NSCLC) and head/neck squamous cell cancer (HNSCC) patients who are already initiating an immune checkpoint inhibitor (su...

A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of INCB050465 in the treatment of Japanese participants diagnosed with previously-treated B-cell lym...

A Phase 2 Study of Pembrolizumab in Patients With Histiocyte/Dendritic Cell Neoplasms and Biologically Selected Subtypes of Relapsed/Refractory Aggressive Lymphomas

This research study is studying a drug called pembrolizumab as a possible treatment for aggressive lymphoma or a histiocyte or dendritic cell neoplasm. The drug involved in this study is:...

A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Subjects With Advanced Solid Tumors

This is a Phase 1, open label, multi-center study of DSP-7888 Dosing Emulsion, administered intradermally in combination with checkpoint inhibitors (Nivolumab or Atezolizumab) in adult sub...

T-Cell PET Imaging With [18F]F-AraG in Lung Cancer

This is a single-center cross-sectional imaging study in patients with localized lung cancer undergoing immunotherapy with or without stereotactic radiation therapy as part of the companio...

Videos

None available.

Medical and Biotech [MESH] Definitions

Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. (From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156)

Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.

A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.

Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.

Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.

Quick Search
Advertisement
 

Relevant Topic

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

review and buy MatBA - Mature B-cell neoplasm array market research data and corporate reports here

Channels Quicklinks